Contraceptive Technology Update – July 1, 2018
July 1, 2018
View Issues
-
Check Your Clinical Practice for LARC Methods
The American College of Obstetricians and Gynecologists now recognizes immediate postpartum placement of either the intrauterine device or the contraceptive implant as a best practice because of the long-acting reversible contraceptive methods’ role in preventing rapid repeat and unintended pregnancy
-
FDA Issues Restrictions for Sterilization Option
The Food and Drug Administration has issued new restrictions regarding the sale and distribution of the permanent contraceptive device, Essure.
-
Push Is on to Combat Drug-resistant Gonorrhea
In a recently released study, Centers for Disease Control and Prevention (CDC) researchers report that while 81% of patients diagnosed with gonorrhea were treated using dual therapy, nearly one in five were treated with a different regimen.
-
Research Examines Self-administered DMPA
New research indicates that use of subcutaneous depot medroxyprogesterone (DMPA-SC, marketed as Sayana Press, Pfizer Inc.) may help women to continue using injectable contraception longer than women who receive traditional intramuscular injections.
-
What’s Your Approach to Abnormal Uterine Bleeding?
Statistics indicate that one-third of outpatient gynecologist visits are for abnormal uterine bleeding, with the condition accounting for more than 70% of gynecologic consultations in the perimenopausal and postmenopausal years.
-
With Funding Announcement, Trump Begins Reshaping Title X
Funding announcement to reshape Title X.